Table 1.

Single-entry STOPP.v3 criteria

Abbreviations: ACEI Angiotensin-converting-enzyme inhibitors, ACS Acute coronary syndrome, AF Atrial fibrillation, ARB Angiotensin II receptor blocker, BMI Body mass index, BP Blood pressure, BPSD Behavioral and psychological symptoms in dementia, CKD Chronic kidney disease,, COPD Chronic obstructive pulmonary disease, COX-2 Cyclooxygenase-2, CV Cardiovascular, dBP diastolic blood pressure, DMARD Disease modifying activity rheumatic drug, IV Intravenous, DOAC Direct oral anticoagulant, DVT Deep venous thrombosis, eGFR estimated glomerular filtration rate, GAVE Gastric antral vascular ectasia, GI Gastro-intestinal, HFpEF Heart failure with preserved ejection fraction, HFrEF Heart failure with reduced ejection fraction, LABA Long-acting beta-agonists, LAMA Long-acting muscarinic antagonists, NSAID Nonsteroidal anti-inflammatory drugs, NYHA New York Heart Association, OAC Oral anticoagulant, pCO2 partial pressure of carbon dioxide, pO2 partial pressure of oxygen, pa02 partial pressure of arterial oxygen, PE Pulmonary embolism, PIM Potentially inappropriate medication, P-gp P-glycoprotein, PPI Proton pump inhibitor, PTH Parathormone, QTc Corrected QT Interval, SaO2 arterial oxygen saturation, SARS-CoV2 Severe acute respiratory syndrome coronavirus 2, sBP systolic blood pressure, SGLT2 Sodium-glucose cotransporter 2, SNRI Serotonin–norepinephrine reuptake inhibitors, SSRI Selective Serotonin Reuptake Inhibitor, T4 Thyroxine, TSH Thyroid stimulating hormone, VKA Vitamin K antagonist

^aacepromazine, chlorpromazine, clozapine, flupenthixol, fluphenzine, levomepromazine, olanzapine, pipothiazine, promazine, thioridazine

^bincluding Ginkgo Biloba, piracetam, pramiracetam, phenylpiracetam, aniracetam, phosphatidylserine, modafinil, L-theanine, omega-3 fatty acids, panax ginseng, rhodiola, creatine

^camiodarone, azithromycin, carvedilol, cyclosporin, dronedarone, itraconazole, ketoconazole (systemic), macrolides, quinine, ranolazine, tamoxifen, ticagrelor, verapamil

^drivaroxaban, apixaban, edoxaban 

^equinolones, macrolides, ondansetron, citalopram (doses > 20 mg/day), escitalopram (doses > 10 mg/day), tricyclic antidepressants, lithium, haloperidol, digoxin, class 1A antiarrhythmics, class III antiarrhythmics, tizanidine, phenothiazines, astemizole, mirabegron

^fACEI’s, ARB’s, amiloride, triamterene